Cargando…
Intravenous Fluid Administration and the Risk of Adverse Outcomes in Sickle Cell Disease Patients Hospitalized for Vaso-Occlusive Crisis
Vaso-occlusive crisis (VOC) is the leading cause of hospitalization in sickle cell disease (SCD). Intravenous fluid (IVF) administration is the usual practice during VOC episodes to slow the sickling process. In the absence of an evidence-based, clear-cut consensus on the optimal choice, route, and...
Autores principales: | Ojo, Ademola S., Ojukwu, Somtochukwu, Asmare, Wassihun, Odipe, Oluwamayowa, Larbi, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635800/ https://www.ncbi.nlm.nih.gov/pubmed/36406833 http://dx.doi.org/10.14740/jh1058 |
Ejemplares similares
-
Improving the Emergency Department Management of Sickle Cell Vaso-Occlusive Pain Crisis: The Role and Options of Sublingual and Intranasally Administered Analgesia
por: Ojo, Ademola S., et al.
Publicado: (2023) -
Fluid overload due to intravenous fluid therapy for vaso‐occlusive crisis in sickle cell disease: incidence and risk factors
por: Gaartman, Aafke E., et al.
Publicado: (2021) -
Sickle cell vaso-occlusive crisis: it’s a gut feeling
por: Lim, Seah H., et al.
Publicado: (2016) -
The Role of Infection in the Pathogenesis of Vaso-Occlusive Crisis in Patients with Sickle Cell Disease.
por: Ahmed, Sagir G.
Publicado: (2011) -
Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis
por: Akinlade, Kehinde Sola, et al.
Publicado: (2014)